Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
12 May 2026
GlobeNewswire
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity
12 May 2026
GlobeNewswire
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
12 May 2026
GlobeNewswire
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
12 May 2026
PR Newswire Association LLC.
TrilliumBiO and Oncobit Launch Advanced Uveal Melanoma Monitoring Solution in the U.S.
12 May 2026
GlobeNewswire
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
12 May 2026
GlobeNewswire
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
12 May 2026
PR Newswire Association LLC.
Avalere Health expands to Japan with a full-service Advisory, Medical, and Marketing offering, led by industry veteran Junji Yokokawa
11 May 2026
PR Newswire Association LLC.
FarmaMondo Group appoints Independent Board Director Natalie Douglas, global pharmaceutical managed access and commercialization pioneer
11 May 2026
GlobeNewswire
Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing
11 May 2026
GlobeNewswire
Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio
11 May 2026
GlobeNewswire
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11 May 2026
PR Newswire Association LLC.
Windham Capital Partners' David Kereiakes Joins AO Foundation Technology Transfer Board to Translate Surgical Innovation into Patient Impact
11 May 2026
PR Newswire Association LLC.
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
09 May 2026
PR Newswire Association LLC.
For the Reasons that Matter: A Multi-Spotlight Campaign Puts Adult Respiratory Health in Focus
07 May 2026
PR Newswire Association LLC.
BC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation
05 May 2026
PR Newswire Association LLC.
Basel Area Life Sciences Supercluster Welcomes New Korean Biopharmas
05 May 2026
PR Newswire Association LLC.
TEN-YEAR PIVOTAL DATA REINFORCE THE LONG-TERM DURABILITY OF EDWARDS' RESILIA TISSUE
04 May 2026
PR Newswire Association LLC.
ADC Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Updates
04 May 2026
Latest News All News
Upcoming Events All Events
- May 2026
- Copenhagen: LSX Nordic Congress
- Basel: Pharma Partnering EU Summit 2026
- London: UK Biotech Day